Crossref
Biological treatment of asthma at the end of the first quarter of the 21st century
Klinická farmakologie a farmacie · 20.04.2026 · 40 (1) · 25-33
DOI: 10.36290/far.2026.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinická farmakologie a farmacie, erschienen am 20.04.2026. Verfasst von Jakub Novosad und 1 weiteren Autor:innen. Die Arbeit nennt 81 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Novosad, J., & Krčmová, I. (2026). Biological treatment of asthma at the end of the first quarter of the 21st century. Klinická farmakologie a farmacie, 40(1), 25-33. https://doi.org/10.36290/far.2026.010
Vancouver
Novosad J, Krčmová I. Biological treatment of asthma at the end of the first quarter of the 21st century. Klinická farmakologie a farmacie. 2026;40(1):25-33. doi:10.36290/far.2026.010
BibTeX
@article{Novosad2026,
author = {Novosad, Jakub and Krčmová, Irena},
title = {Biological treatment of asthma at the end of the first quarter of the 21st century},
journal = {Klinická farmakologie a farmacie},
year = {2026},
volume = {40},
number = {1},
pages = {25--33},
doi = {10.36290/far.2026.010}
}
EUVIMED